LRG GIST Patient Registry

Patterns of Care and Outcomes of Patients With METAstatic Gastrointestinal Stromal Tumors (METAGIST)

NCT03963544 ·Status: COMPLETED

Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)

NCT02147145 ·Status: COMPLETED

Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)

NCT01271712 ·Status: COMPLETED ·Phase: PHASE3

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

NCT01689376 ·Status: NO_LONGER_AVAILABLE

An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States

NCT06321055 ·Status: COMPLETED

Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

NCT01068769 ·Status: COMPLETED ·Phase: PHASE2

Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST

NCT02353052 ·Status: UNKNOWN

Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.

NCT06087263 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST

NCT04148092 ·Status: APPROVED_FOR_MARKETING

Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)

NCT05080621 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance

NCT00367861 ·Status: COMPLETED ·Phase: PHASE3

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

NCT01646593 ·Status: NO_LONGER_AVAILABLE

Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST)

NCT01462994 ·Status: COMPLETED ·Phase: PHASE3

Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting

NCT00877045 ·Status: COMPLETED

BGT007H Cells for the Treatment of Refractory Digestive System Tumors

NCT06104215 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial

NCT00640692 ·Status: WITHDRAWN

Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients

NCT07096609 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT07379047 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST

NCT05366816 ·Status: RECRUITING ·Phase: PHASE2

Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.

NCT03944304 ·Status: COMPLETED ·Phase: PHASE2

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

NCT02638766 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

NCT01323400 ·Status: COMPLETED ·Phase: PHASE2

Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)

NCT02443948 ·Status: UNKNOWN

A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

NCT01396148 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib

NCT00570635 ·Status: COMPLETED ·Phase: PHASE2